Sub-Regional Body Composition and Clinical Endpoints in Myotonic Dystrophy Type 2 (DM2)

被引：0
|
作者：
Puwanant, Araya [1 ]
Isfort, Michael C. [1 ]
Kelleher, Annmarie [1 ]
Brown, Kathryn [1 ]
Su, Xiaowei William [1 ]
Clemens, Paula R. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
ANNALS OF NEUROLOGY | 2018年 / 84卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S275
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [41] Strong association between myotonic dystrophy type 2 (DM2) and frequency of auto-immune diseases and autoantibody formation
    van de Logt, A.
    Tieleman, A. A.
    den Broeder, A. A.
    van Engelen, B. G. M.
    [J]. NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 745 - 745
  • [42] The myotonic dystrophy type 2 (DM2) CCTG expansion does not prevent allele specific ZNF9 expression
    Malikowski, JM
    Moseley, ML
    Mosemiller, AK
    Jin, D
    Schoser, B
    Kress, W
    Ricker, K
    Day, JW
    Ranum, LPW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 584 - 584
  • [43] Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2
    Cardani, Rosanna
    Giagnacovo, Marzia
    Botta, Annalisa
    Rinaldi, Fabrizio
    Morgante, Alessandra
    Udd, Bjarne
    Raheem, Olayinka
    Penttila, Sini
    Suominen, Tiina
    Renna, Laura V.
    Sansone, Valeria
    Bugiardini, Enrico
    Novelli, Giuseppe
    Meola, Giovanni
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (10) : 2090 - 2099
  • [44] Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1)
    Vihola, A.
    Sirito, M.
    Bachinski, L.
    Olufemi, S.
    Raheem, O.
    Suominen, T.
    Udd, B.
    Krahe, R.
    [J]. NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 858 - 858
  • [45] Health-related quality of life in myotonic dystrophy type 1 (DM1) and type 2 (DM2): Correlations with indexes of cognitive and behavioral abnormalities
    Sansone, V
    Gandossini, S
    Cotelli, M
    Calabria, M
    Zanetti, O
    Apolone, G
    Meola, G
    [J]. NEUROLOGY, 2006, 66 (05) : A151 - A152
  • [46] A case report of possible myotonic dystrophy without DM1 or DM2 gene mutations. Clinical and pathologic analyses
    Takao, Masaki
    Sato, Hideki
    Suzuki, Norihiro
    Nishino, Ichizo
    Yoshikawa, Tsutomu
    Ishihara, Tadayuki
    [J]. BRAIN PATHOLOGY, 2006, 16 : S145 - S145
  • [47] Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)
    Botta, A
    Caldarola, S
    Vallo, L
    Bonifazi, E
    Fruci, D
    Gullotta, F
    Massa, R
    Novelli, G
    Loreni, F
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (03): : 329 - 334
  • [48] Chromogenic in situ hybridization (CISH) on muscle sections - a new, direct method for molecular diagnosis of myotonic dystrophy type 2 (DM2)
    Vihola, A
    Sallinen, R
    Haapasalo, H
    Kalimo, H
    Paetau, A
    Zhang, S
    Krahe, R
    Udd, B
    [J]. NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 618 - 618
  • [49] Cardiac conduction abnormalities are infrequent in myotonic dystrophy type 2 (DM2) patients: a 10 years follow-up study
    Meola, G
    Sansone, V
    Pazzi, A
    Krahe, R
    De Ambroggi, L
    [J]. NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 587 - 587
  • [50] Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2):: A quantitative 31P-MRS and MRI study
    Schneider-Gold, C
    Beer, M
    Köstler, H
    Buchner, S
    Sandstede, J
    Hahn, D
    Toyka, KV
    [J]. MUSCLE & NERVE, 2004, 30 (05) : 636 - 644
12345